Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar 29:7:28-35.
doi: 10.2174/1874192401307010028. Print 2013.

Quantitative Immunohistochemistry of Desmosomal Proteins (Plakoglobin, Desmoplakin and Plakophilin), Connexin-43, and N-cadherin in Arrhythmogenic Cardiomyopathy: An Autopsy Study

Affiliations

Quantitative Immunohistochemistry of Desmosomal Proteins (Plakoglobin, Desmoplakin and Plakophilin), Connexin-43, and N-cadherin in Arrhythmogenic Cardiomyopathy: An Autopsy Study

Fabio Tavora et al. Open Cardiovasc Med J. .

Abstract

Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic disorder related to mutations in desmosomal proteins. The current study tests the hypothesis that immunohistochemical staining for desmosomal proteins is of diagnostic utility by studying autopsy-confirmed cases of ARVC.

Methods and results: We studied 23 hearts from patients dying suddenly with ARVC. Control subject tissues were 21 hearts from people dying from non-cardiac causes (n=15), dilated cardiomyopathy (n=3) and coronary artery disease (n=3). Areas free of fibrofatty change or scarring were assessed on 50 sections from ARVC (24 left ventricle, 26 right ventricle) and 28 sections from controls. Immunohistochemical stains against plakoglobin, plakophilin, desmoplakin, connexin-43, and N-cadherin were applied and area expression analyzed by computerized morphometry. Desmin was stained as a control for fixation and similarly analyzed. The mean area of desmin expression was similar in controls and ARVC (86% vs. 85%, p=0.6). Plakoglobin expression was 4.9% ± 0.3% in controls, vs. 4.6% ± 0.3% in ARVC (p=0.3). Plakophilin staining was 4.8% ± 0.3% in controls vs. 4.4% ± 03% in ARVC (p=0.3). Desmoplakin staining was 3.4% in controls vs. 3.2 ± 0.2% in ARVC (p=0.6). There were no significant differences when staining was compared between right and left ventricles (all p > 0.1). For non-desmosomal proteins, the mean area of connexin-43 staining showed no significant difference by presence of disease.

Conclusions: The small and insignificant decrease in junction protein expression in ARVC suggests that immunohistochemistry is not a useful tool for the diagnosis.

Keywords: ARVC; arrhytmogenic cardiomyopaty; autopsy.; sudden death.

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
ARVC, fibrofatty change. A: Section of left ventricle showing areas of fatty change with fibrosis surrounding individual myocytes. B: A section of left ventricle from a different patient, with areas of fat, randomly distribution in areas of scar and myocytes. C: A section of right ventricle single myocytes interspersed with areas of scarring and fatty change. D: Fibrofatty change in the right ventricle. Note fibrosis and fat, with collagen surrounding individual myocytes near the endocardial surface.
Fig. (2)
Fig. (2)
A. Immunohistochemical stain for gamma-catenin in a patient with ARVC. A digitized section with intercalated discs staining with brown diaminobenzidine counterstain. B. Staining after digital subtraction colorizing brown target as yellow, for computerized assessment of percentage of staining. In this case yellow percentage of myocyte (cyan) area was rendered as 3.97%.
Fig. (3)
Fig. (3)
Immunohistochemical staining, ARVC patients, digitized unmixed composite images, prior to color reassignment. A. Plakoglobin (antibody JUP). There is normal intensity of staining, similar to controls. B Plakoglobin (antibody JUP, higher magnification), showing normal staining intensity. B. Plakoglobin (antibody gamma catenin), showing normal intensity of staining. D. Plakophilin, showing normal intensity of staining. E. Desmoplakin, showing normal intensity of staining. F. N-cadherin, showing normal intensity of staining.
Fig. (4)
Fig. (4)
Immunohistochemical staining, control patients, digitized unmixed composite images, prior to color reassignment. A. Plakoglobin (antibody JUP) showing normal intensity of staining. B Plakoglobin (antibody JUP, higher magnification) showing normal intensity of staining. B. Plakoglobin (antibody gamma catenin) showing normal intensity of staining. D. Plakophilin. showing normal intensity of staining E. Desmoplakin showing normal intensity of staining. F. N-cadherin showing normal intensity of staining.

Similar articles

Cited by

References

    1. Dalal D, Molin LH, Piccini J, et al. Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. Circulation. 2006;113:1641–9. - PubMed
    1. Gerull B, Heuser A, Wichter T, et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet. 2004;36:1162–4. - PubMed
    1. Heuser A, Plovie ER, Ellinor PT, et al. Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet. 2006;79:1081–8. - PMC - PubMed
    1. Pilichou K, Nava A, Basso C, et al. Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation. 2006;113:1171–9. - PubMed
    1. Syrris P, Ward D, Asimaki A, et al. Desmoglein-2 mutations in arrhythmogenic right ventricular cardiomyopathy: a genotype-phenotype characterization of familial disease. Eur Heart J. 2007;28:581–8. - PubMed

LinkOut - more resources